» Articles » PMID: 37603276

Extracellular Vesicles for Muscle Atrophy Treatment

Overview
Date 2023 Aug 21
PMID 37603276
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal muscle atrophy is a progressive chronic disease associated with various conditions, such as aging, cancer, and muscular dystrophy. Interleukin-6 (IL-6) is highly correlated with or plays a crucial role in inducing skeletal muscle atrophy. Extracellular vehicles (EVs), including exosomes, mediate cell-cell communication, and alterations in the genetic material contained in EVs during muscle atrophy may impair muscle cell signaling. Transplantation of muscle progenitor cell-derived EVs (MPC-EVs) is a promising approach for treating muscle diseases such as Duchenne muscular dystrophy (DMD). Moreover, stem cell-derived EVs with modification of microRNAs (e.g., miR-26 and miR-29) have been reported to attenuate muscle atrophy. Unbiased RNA-Seq analysis suggests that MPC-EVs may exert an inhibitory effect on IL-6 pathway. Here, we review the latest advances concerning the mechanisms of stem cell/progenitor cell-derived EVs in alleviating muscle atrophy, including anti-inflammatory and anti-fibrotic effects. We also discuss the clinical application of EVs in the treatment of muscle atrophy.

Citing Articles

Treatment of Denervated Muscle Atrophy by Injectable Dual-Responsive Hydrogels Loaded with Extracellular Vesicles.

Bu Z, Jing J, Liu W, Fan Z, Huang J, Zhou Z Adv Sci (Weinh). 2025; 12(10):e2412248.

PMID: 39836492 PMC: 11905034. DOI: 10.1002/advs.202412248.


Transcriptome sequencing analysis reveals the molecular mechanism of sepsis-induced muscle atrophy.

Yan D, Zhang J, Yan W, Song F, Luo X, Miao H J Thorac Dis. 2024; 16(11):7751-7770.

PMID: 39678885 PMC: 11635243. DOI: 10.21037/jtd-24-1665.


In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment.

Faiella M, Botti G, Dalpiaz A, Gnudi L, Goyenvalle A, Pavan B Pharmaceutics. 2024; 16(8).

PMID: 39204368 PMC: 11360444. DOI: 10.3390/pharmaceutics16081023.


Caveolin and NOS in the Development of Muscular Dystrophy.

Nakashima M, Suga N, Yoshikawa S, Matsuda S Int J Mol Sci. 2024; 25(16).

PMID: 39201459 PMC: 11354531. DOI: 10.3390/ijms25168771.


Exploring the Role of Extracellular Vesicles in Skeletal Muscle Regeneration.

Porcu C, Dobrowolny G, Scicchitano B Int J Mol Sci. 2024; 25(11).

PMID: 38892005 PMC: 11171935. DOI: 10.3390/ijms25115811.

References
1.
Qin W, Dallas S . Exosomes and Extracellular RNA in Muscle and Bone Aging and Crosstalk. Curr Osteoporos Rep. 2019; 17(6):548-559. PMC: 7083338. DOI: 10.1007/s11914-019-00537-7. View

2.
He C, He W, Hou J, Chen K, Huang M, Yang M . Bone and Muscle Crosstalk in Aging. Front Cell Dev Biol. 2020; 8:585644. PMC: 7758235. DOI: 10.3389/fcell.2020.585644. View

3.
You Y, Ikezu T . Emerging roles of extracellular vesicles in neurodegenerative disorders. Neurobiol Dis. 2019; 130:104512. PMC: 6689424. DOI: 10.1016/j.nbd.2019.104512. View

4.
Garcia-Contreras M, Shah S, Tamayo A, Robbins P, Golberg R, Mendez A . Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes. Sci Rep. 2017; 7(1):5998. PMC: 5519761. DOI: 10.1038/s41598-017-05787-y. View

5.
Nguyen M, Karunakaran D, Geoffrion M, Cheng H, Tandoc K, Matic L . Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration. Arterioscler Thromb Vasc Biol. 2017; 38(1):49-63. PMC: 5884694. DOI: 10.1161/ATVBAHA.117.309795. View